Login / Signup

Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study.

Daniel Ortega-QuijanoDaniel Ortega-QuijanoAna Suarez-ValleJuan Jimenez-CauheP Jaen-OlasoloM Fernandez-Guarino
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
The Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Skin lesions have been described in confirmed COVID-19 patients as potential manifestations of the disease1 . Different prevalence rates have been reported in hospitalized patients from January to May 2020, ranging from 0.2 to 20.5%.2-5 Prevalence rates in studies where dermatologists did not perform the initial physical examination may be underestimated2,5,6 . A second wave of the COVID-19 epidemic has emerged in European countries starting in late August. Spain has been one of the most affected regions. However, cutaneous findings have been scarcely reported during this time period.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • risk factors
  • infectious diseases
  • physical activity
  • soft tissue
  • mental health
  • risk assessment